Syk-IN-3
1312534-69-2
|
SYK-58
1000410-00-3
|
Syk Inhibitor II dihydrochloride
227449-73-2
|
Syk Inhibitor II dihydrochloride dihydrate
1965323-05-0
|
SYK/JAK-IN-1
2737326-28-0
|
Syk-IN-1
1491150-77-6
|
Syk-IN-23
2040321-29-5
|
Syk inhibitor II
726695-51-8
|
Syk Kinase Peptide Substrate
865778-47-8
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
|
N-[3-(Aminooxy)propyl]-N-butyl-1-butanamine
127437-46-1
|
